| Page 1270 | Kisaco Research
 

Sungyong Kang

Criminal Intelligence Officer / Financial Crime and Anti-Corruption Center
INTERPOL

Sungyong Kang, an S.J.D. (Ph.D. in Law equivalent) and Esq., is working as a Criminal Intelligence Officer at the INTERPOL Financial Crime and Anti-Corruption Center where his main duty is to coordinate the international cooperation to trace, freeze/seize and confiscate the criminal proceeds. Prior to joining the INTERPOL, he worked as a researcher and an adjunct professor at the Korea National Police University where he focused on the financial crime exploiting new technologies, such as Blockchain, Artificial Intelligence and Metaverse, etc.

Sungyong Kang

Criminal Intelligence Officer / Financial Crime and Anti-Corruption Center
INTERPOL

Sungyong Kang

Criminal Intelligence Officer / Financial Crime and Anti-Corruption Center
INTERPOL

Sungyong Kang, an S.J.D. (Ph.D. in Law equivalent) and Esq., is working as a Criminal Intelligence Officer at the INTERPOL Financial Crime and Anti-Corruption Center where his main duty is to coordinate the international cooperation to trace, freeze/seize and confiscate the criminal proceeds. Prior to joining the INTERPOL, he worked as a researcher and an adjunct professor at the Korea National Police University where he focused on the financial crime exploiting new technologies, such as Blockchain, Artificial Intelligence and Metaverse, etc. Before then, he was an investigator of Korea National Police Agency, and he successfully investigated diverse high profile financial crimes leading his team to be awarded as the best investigation team in Seoul.

Sungyong Kang is an author of many legal researches published by renowned international journals including International & Comparative Law Quarterly (Cambridge University Press), Michigan Journal of International Law (forthcoming, Michigan Law School), etc. He is also a frequent speaker at the conferences organized by respected international entities including FATF, UNTOC, Basel Institute on Governance, EUROPOL and INTERPOL, etc.

 

Gurleen Virk

Responsible Innovation Program Manager- Responsible AI, ML
Google

Gurleen Virk

Responsible Innovation Program Manager- Responsible AI, ML
Google

Gurleen Virk

Responsible Innovation Program Manager- Responsible AI, ML
Google
 

Adhar Walia

Senior Director of Product Management, AI ML
CVS Health

Adhar Walia

Senior Director of Product Management, AI ML
CVS Health

Adhar Walia

Senior Director of Product Management, AI ML
CVS Health

Joshua Kennedy-Smith, RTW Investments

“Good mix of academic and industrial attendees.”

Joshua Kennedy-Smith, RTW Investments

Jordi Gràcia, Almirall

“It’s been a while since I attended a meeting and felt I had learned so
many things. Great atmosphere, excellent interactions. Superb speakers.
Good time management, sufficient time for questions. Good location.
Smooth organization.”

Jordi Gràcia, Almirall

Yuqing Huang Suzhou, Kintor Pharmaceuticals

“A lot of data on PROTAC research has been disclosed at this event. And also,
many leaders in PROTACs shared their experience and concerns about their
development. Many start-up companies also delivered their progress. We are
able to discuss future directions as well as difficulties with experts from both
industry and the academic area and learned a lot.”

Yuqing Huang Suzhou, Kintor Pharmaceuticals

 

Megan Murphy

Associate Director of Events and Engagement
PCOS Challenge

Meg Murphy is the Associate Director of Events and Engagement at PCOS Challenge: The National Polycystic Ovary Syndrome Association. Serving 57,000 members, PCOS Challenge is the leading nonprofit support organization globally that is advancing the cause for people affected by PCOS. PCOS Challenge hosts the largest and most influential PCOS educational events in the nation, which serve both patients and healthcare providers. They are the leading organization advocating for and shaping public policy with regard to women and girls impacted by polycystic ovary syndrome.

Megan Murphy

Associate Director of Events and Engagement
PCOS Challenge

Megan Murphy

Associate Director of Events and Engagement
PCOS Challenge

Meg Murphy is the Associate Director of Events and Engagement at PCOS Challenge: The National Polycystic Ovary Syndrome Association. Serving 57,000 members, PCOS Challenge is the leading nonprofit support organization globally that is advancing the cause for people affected by PCOS. PCOS Challenge hosts the largest and most influential PCOS educational events in the nation, which serve both patients and healthcare providers. They are the leading organization advocating for and shaping public policy with regard to women and girls impacted by polycystic ovary syndrome.


Meg attended her first PCOS Challenge symposium in 2014 and learned more in that one afternoon than she had in years as a patient. She immediately signed on as a volunteer and went on to become a Patient Advisory Board member. In January 2022, Meg joined the PCOS Challenge team full-time. Meg is passionate about empowering other people with PCOS to advocate for their health.


Prior to joining PCOS Challenge, Meg worked in the Office of Research Affairs at UC San Diego. She is a runner and recently launched the PCOS Challenge Race Team at the Los Angeles Marathon. Meg received her B.A. from Boston University and resides in San Diego, California with her husband.

 

 

David Stern

CEO
Boston IVF

David Stern has over 28 years of women’s health experience and has devoted the majority of his career to the fertility industry. He has held executive leadership positions and built successful teams while launching numerous products in pharmaceutical and biotech markets world-wide. Currently, David serves as the CEO of Boston IVF, one the largest IVF center networks in the United States with 11 full service IVF centers and over 30 satellite centers nationwide.

 

David Stern

CEO
Boston IVF

David Stern

CEO
Boston IVF

David Stern has over 28 years of women’s health experience and has devoted the majority of his career to the fertility industry. He has held executive leadership positions and built successful teams while launching numerous products in pharmaceutical and biotech markets world-wide. Currently, David serves as the CEO of Boston IVF, one the largest IVF center networks in the United States with 11 full service IVF centers and over 30 satellite centers nationwide.

 

David served as CEO of Symbiomix Therapeutics a venture backed biotech company. He led the transition of the company from development stage to commercial launch in the US, prior to its acquisition by Lupin Pharmaceuticals in 2017. He served on the board of California Cryobank and has held executive positions in startup companies in the women’s healthcare market, building commercial teams, developing strategy and expanding scientific partnerships for Celmatix, Ohana and OvaScience.

 

David was the Senior Vice President and Head of the Global Business Franchise for Fertility at Merck Serono, responsible for the strategic development and growth of the portfolio world-wide. Prior to his global role, he was responsible for the US commercial operations in the Fertility, HIV and Growth Hormone markets. David started his career in women’s health with Organon Pharmaceutics. He has an MBA with a concentration in International Marketing and Management from the F.W. Olin School of Business at Babson College and holds a Bachelors’ degree in Biology from Brandeis University.